Tirofiban hydrochloride
NDC 68083-145, Tirofiban, injection, solution, from Gland Pharma Limited.
- Product NDC
- 68083-145
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206888
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIROFIBAN HYDROCHLORIDE12.5 mg/250mL
Pharmacologic classes
Decreased Platelet Aggregation [PE]; Platelet Aggregation Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-145-01 | 68083014501 | 1 CONTAINER in 1 CARTON (68083-145-01) / 250 mL in 1 CONTAINER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fa3ac570-f9f6-474c-a920-bd0cf03045ac
Use it
Look up 68083-145 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.